ABSTRACT -Hypothyroidism induced by xenobiotic treatment was analyzed for possible underlying mechanism(s) on the basis of different responses of the thyroid gland and the liver, using a newly-created database of repeated-dose toxicity of 500 chemicals. Two mechanisms are proposed: direct inhibition of thyroid hormone biosynthesis in the thyroid gland, and stimulated degradation of thyroid hormone by induction of hepatic drug-metabolizing enzymes. In the database there were 10 chemicals inducing hypertrophy/hyperplasia of follicular cells in the thyroid gland and having data on thyroid glands. On the basis of the chemical structure and information available in the literature, we judged three chemicals to be typical thioamide derivatives that act directly on the thyroid gland, and the others as non-thioamide derivatives that were unlikely to have any direct action on the thyroid gland. All these chemicals were classified into two groups using the ratios of relative weight increase rate of thyroid gland versus that of the liver. These values were at least 1.7, but 3.2 or more in the most of the cases for thioamide derivatives, and 1.2 or less for non-thioamide derivatives. This background analysis suggests the feasibility of parametersupported speculation on the possible underlying mechanism when new repeated-dose toxicity data on hypothyroidism becomes available.
INTRODUCTION
The enlargement of the thyroid gland due to hypertrophy and hyperplasia of follicular cells sometimes occurs due to the toxic effects of repeated doses of various chemicals. This can be often understood as hypothyroidism, a functional decline of the thyroid gland. The thyroid gland, although small, is a unique form of tissue that is crucial to the metabolism of the entire body. Thyroid follicular cells produce thyroid hormones such as thyroxine (T 4 ) and triiodothyronine (T 3 ). The biosynthesis is enhanced by thyroid-stimulating hormone (TSH). If blood T 4 and T 3 levels fall for any reason, secretion of TSH by the pituitary gland increases due to a loss of negative feedback inhibition along the hypothalamus-pituitary-thyroid axis.
There are several mechanisms that reduce T 4 and T 3 biosynthesis in the thyroid gland, including inhibition of iodine uptake, inhibition of peroxidase, and blockade of thyroid hormone secretion (Capen, 2008) . Although numerous chemicals are known to inhibit thyroid peroxidase activity, it is generally believed that thioamide derivatives (such as thiourea, thiouracil, propylthiour-acil, methimazole, carbimazole, and goitrin) are the key structural chemicals that inhibit thyroid peroxidase. Propylthiouracil is the most potent chemical in rats, based on observations of a reduction in iodine concentration in the thyroid gland 10 days after oral administration (Astwood et al., 1945; McGinty and Bywater, 1945) . There are several other chemicals which are neither structurally related to thioamide derivatives nor belong to groups of other thyroid peroxidase inhibitors (Capen, 2008) . Some of them, such as phenobarbital, pregnenolone-16α-carbonitrile, and pyrethrins, induce hepatic microsomal enzymes and disrupt thyroid function in rats (Hood et al., 1999; Finch et al., 2006) . The increased activity of uridine 5′-diphospho (UDP)-glucuronyltransferase in the liver by induction of hepatic microsomal enzymes reduces the levels of T 4 in the blood, which leads to a reduction of feedback inhibition along the hypothalamus-pituitary-thyroid axis. The induction of hepatic microsomal enzymes is closely correlated with hepatomegaly and hypertrophy of the centrilobular hepatocytes. At the same time, some increase in thyroid gland weight occurs with hypertrophy of the follicular cells.
Speculation on the mechanism of hypothyroidism caused by each chemical is not easy, since the data set of toxicity tests, obtained according to appropriate test guidelines, does not include any data on mechanisms, such as the enzyme activity of thyroid peroxidase in the thyroid gland and drug metabolism in the liver. Hood et al. (1999) demonstrated time-dependent changes in the relative weights of thyroid and liver after administration of phenobarbital, pregnenolone-16α-carbonitrile, and propylthiouracil, accompanied by those of blood T 4 and T 3 levels. The degree of changes in the weights of both organs induced by propylthiouracil appeared to be higher than those induced by hepatic enzyme inducers. In the case of direct action, the liver may show a certain amount of enlargement, although drastic hypertrophy of the thyroid gland is observed at an early stage. In the case of induction of hepatic drug-metabolizing enzymes, the degree of correlation between the response of the liver and the thyroid gland has not hitherto been analyzed in detail. Therefore, it would be valuable if the possible mechanism of hypothyroidism caused by other chemicals could be predicted by comparing the degree of increase in the weights of both organs, if the thyroid gland shows enlargement in repeated-dose studies. The lack of studies giving an accurate comparison of the response of the two organs prompted us to undertake this investigation.
In mid-2012, we released a repeated-dose toxicity database for 500 chemicals, the Hazard Evaluation Support System Database (HESS DB) (Hayashi and Sakuratani, 2011; Abe et al., 2012) . The database comprises data on histopathology and organ weight from test results, and has a search function for chemicals that cause specific histopathological changes. We used the HESS DB to select chemicals that caused hypertrophy/hyperplasia of thyroid follicular cells and to retrieve data on relative thyroid and liver weights following administration of these chemicals. We compared the degree of response of both organs, and attempted to clarify whether hypertrophy/hyperplasia of thyroid follicular cells occurs as a result of direct action of the chemicals on the thyroid gland or via induction of drug-metabolizing enzymes in the liver.
MATERIALS AND METHODS

Database
The HESS DB currently contains toxicity data on repeated-dose studies in rats for 500 chemicals. It includes test data on hematology, blood chemistry, absolute and relative organ weight, necropsy and histopathology, and testing conditions, as well as a summary of the study evaluated by experts in toxicology (Hayashi and Sakuratani, 2011; Abe et al., 2012) . This database has been accessible at no charge from the website of the National Institute of Technology and Evaluation (NITE), Japan, since June 2012 (http://www.safe.nite.go.jp/english/kasinn/qsar/hess-e. html). Most toxicity studies presented in the HESS DB have been performed in compliance with the standard test guidelines and Good Laboratory Practice; and other studies have been performed in conditions similar to those mentioned in the standard test guidelines and have been reported in peer-reviewed journals. This database comprises the test results for both males and females. From the results of the toxicity study performed according to OECD Guideline 422, "Combined Repeated-dose toxicity Study with a Reproductive/Developmental Toxicity Screening test" (OECD, 1996) , data from male rats only were included in the HESS DB because female rats have a history of pregnancy and delivery.
Selection of chemicals that induced hypothyroidism and retrieval of data on thyroid and liver responses
The HESS DB has a search function for chemicals that induce similar histopathological changes (Abe et al., 2012) . The search function is based on a thesaurus of histopathological findings constructed for the DB (Nishikawa, 2010) . To select chemicals that induce hypothyroidism, "hypertrophy of thyroid gland in the endocrine system" was used as a search term in the histopathology tab of the main window of HESS DB ( gland in endocrine system" was also utilized as another search term. The HESS DB displayed, as search results, the structures of chemicals which caused hypertrophy and hyperplasia of thyroid gland in repeated-dose studies at any dose. The results window for these histopathological findings was opened (Fig. 1B) . Studies in which hypertrophy/hyperplasia of the thyroid gland was clearly observed as a toxic effect of the tested chemicals were evaluated and selected on the basis of dose-dependency. For the present analysis, data on the relative organ weights of thyroid gland and liver at all tested doses were then retrieved when such data were available (Fig. 1C) . In these cases, incidences of hypertrophy/hyperplasia of follicular cells in the thyroid gland or hypertrophy/swelling of centrilobular hepatocytes were also retrieved from the Results window of histopathological findings (Fig. 1B) .
Calculation of thyroid gland-liver response ratio
To quantify the degree of response of thyroid gland and liver at the administered dose in comparison with the control, relative weight increase (ReWI) rate was calculated for respective organs at the highest and second highest doses as follows.
ReWI rate = relative organ weight at administration dose relative organ weight at control Then, to determine the ratio of ReWI of thyroid gland versus that of liver, the thyroid gland-liver response ratio (TLR ratio) was calculated as follows.
TLR ratio = ReWI rate [thyroid gland] ReWI rate [liver] TLR ratio was compared between selected chemicals, and was addressed using the toxicological mechanism information available in the literature.
RESULTS
Hypertrophy/hyperplasia of and weight response of thyroid gland and liver to chemical substances that induce hypothyroidism
We selected 22 chemicals that caused hypertrophy/ hyperplasia of the thyroid gland using the HESS DB. We then searched the DB for availability of data on weight of thyroid gland. The selected numbers of chemicals and studies totaled 10 and 11, respectively. The DB contained two studies on one of these chemicals. The names of the chemicals and the original reports of the study are as follows.
Propylthiouracil (CAS number: 51-52-5) (Yamasaki et al., 2002) ; 2-mercaptobenzimidazole (1) (583-39-1) (MHLW, 1996) ; 2-mercaptobenzimidazole (2) (583-39-1) (Kawasaki et al., 1998) ; ethylenethiourea (96-45-7) (MHLW, 2005) ; phenobarbital sodium (57-30-7) (Kojima et al., 2009 ); 3,5-xylidine (108-69-0) (MHLW, 1997a); 2-ethylhexan-1-yl diphenyl phosphate (1241-94-7) (MHLW, 1997b); 1,1,2,2-tetrabromoethane (79-27-6) (MHLW, 2003a); dicyclopentan-1-ylsilanediol (211495-85-1) (MHLW, 2001); 2-benzotriazol-2-yl-4,6-di-tertbutylphenol (3846-71-7) (MHLW, 2003b); and 4-methyl-2,4-diphenylpent-1-ene (6362-80-7) (MHLW, 2007) . The study information is summarized in Table 1 .
The chemicals comprise three thioamide derivatives (4 study data) and 7 non-thioamide derivatives (7 study data). It was previously demonstrated that the three thioamide derivatives inhibited thyroperoxidase or lactoperoxidase activity in vitro. They decreased T 4 and T 3 levels and increased TSH levels in the blood, and were accompanied by increased thyroid weight in rats (Doerge, 1986 (Doerge, , 1988 Doerge and Takazawa, 1990; Freyberger and Ahr, 2006; Kawasaki et al., 1998; Yamasaki et al., 2002) . Of the seven non-thioamide derivatives, phenobarbital was shown to induce T 4 and T 3 UDP-glucuronyltransferase activity and increase serum TSH, accompanied by increased liver weight and thyroid follicular cell proliferation (Hood et al., 1999; Hood and Klaassen, 2000; Klaassen and Hood, 2001 ). An increase in microsomal glucuronyltransferase was observed in rats treated with xylidine isomers (Magnusson et al., 1979) . For the remaining five nonthioamides, no particular references were found in terms of enzyme activities or the levels of these hormones in the blood. We then retrieved the data on incidences of hypertrophy/hyperplasia of follicular cells of the thyroid gland or hypertrophy/swelling of the centrilobular hepatocytes and the relative weights of both organs at all the tested dose from the HESS DB (Table 2 ). Both the histopathological changes and relative organ weight increases were more prominent in the thyroid gland than in the liver for thioamide derivatives, whereas they were almost equivalent between the two organs for non-thioamide derivatives.
Comparison of the response of thyroid gland versus that of liver for thioamides and non-thioamides
Using the data on relative weight of thyroid gland and liver, relative weight increase rate (ReWI rate) was calculated for both thyroid gland and liver at the two highest doses versus the control dose. The thyroid gland-liver response (TLR) ratio was then calculated as a ratio of ReWI rate [thyroid gland] versus ReWI rate [liver] . These values are shown in Table 3 . In the case of propylthiouracil, ReWIs were 2.77 for the thyroid gland and 0.86 for the liver in males at the highest dose (1 mg/kg/day) where the thyroid responses were statistically significant. The TLR ratio was 3.21, suggesting the response of the thyroid gland to be clearly greater than that of the liver. For 2-mercaptobenzimidazole (1), 2-mercaptobenzimidazole (2) and ethylenethiourea, the TLR ratios were 4.59, 8.46 and 1.70, respectively, at the highest doses. Taken together, TLR ratios for thioamide derivatives were at least 1.7, but 3.2 or more than in most cases.
For the seven non-thioamide chemicals (phenobarbital sodium, 3,5-xylidine, 2-ethylhexan-1-yl diphenyl phosphate, 1,1,2,2-tetrabromoethane, dicyclopentan-1-ylsilanediol, 2-benzotriazol-2-yl-4,6-di-tert-butylphenol, and 4-methyl-2,4-diphenylpent-1-ene), the TLR ratios were 0. 75, 1.15, 0.86, 0.77, 1.03, 0.55, and 0.87, respectively, at the highest doses. At the second highest dose, hepatic responses generally occurred, but the thyroid gland did not always respond. Taken together, TLR ratios for nonthioamide derivatives were below 1.2.
DISCUSSION
Increased organ weights and hypertrophy/hyperplasia of the follicular cells in the thyroid gland are sometimes observed as toxic effects of repeated administration of chemical substances. In this study, we searched for chemical substances that cause the toxicity, and retrieved the data on relative organ weights of the thyroid gland and liver using a newly-developed repeated-dose toxicity database, the HESS DB (Hayashi and Sakuratani, 2011; Abe et al., 2012) . Based on the chemical structure and ratio of relative weight increase of thyroid gland versus liver (TLR ratio), we found a clear difference in the ratio between thioamides, which directly act on thyroid gland, and non-thioamides, which appear to be hepatic drugmetabolizing enzyme inducers.
Pathological changes such as hypertrophy, hyperplasia, and swelling are subtle and often dependent on the judgment of the pathologist. We therefore utilized the relative weights of the thyroid gland and the liver as a quantitative indicator to compare the degree of response of both organs. The final comparison was performed with TLR ratio at doses that usually induced a greater than 10% increase in the weight of the thyroid gland. Our results showed the TLR ratios for thioamide derivatives were at least 1.7, but 3.2 or more in most cases, whereas the ratios were less than 1.2 for non-thioamide derivatives. Given that phenobarbital and xylidine isomers induce hepatic glucuronyltransferase, and that the remaining non-thioamides were not structurally similar to any chemicals known to act directly on the thyroid gland, we conclude that the non-thioamide derivatives cause hypothyroidism by inducing hepatic drug-metabolizing enzymes. The toxicity studies used in our analysis varied according to strain and age of rat, administration route, period and dose, making it difficult to set a single absolute TLR threshold ratio for classification of antithyroid chemicals according to whether they act directly or indirectly. From the analysis in this study, we propose that direct action is highly likely at more than 1.7, indirect mechanisms are probable at less than 1.2, and both mechanisms are possible at 1.2 -1.7. To achieve a more precise criterion, it will be necessary to look at histopathological data and to determine the inhibitory effect of thyroperoxidase or lactoperoxidase activities in vitro, or the biosynthetic activities of thyroid hormones in vivo. However, this parame- ter might be useful to support speculation as to possible mechanisms. Hood et al. (1999) administered three substances to rats for 90 days and obtained the time course of relative weights of the liver and thyroid gland. On the basis of the data at 60 days, we calculated the ReWI of thyroid gland and liver, and TLR ratio (Table 4 ). The ratio of propylthiouracil was 6.48. The ratio of non-thioamide derivatives was found to be 1.01 for phenobarbital and 1.14 for pregnenolone-16α-carbonitrile, both of which are inducers of drug-metabolizing enzymes in the rat liver. These results are consistent with our results, thus corroborating the usefulness of this value in predicting the possible mechanism of hypothyroidism, primarily when new toxicity test data becomes available.
In conclusion, we quantified the differences in response of the thyroid gland versus liver for chemicals that produce hypothyroidism. There was a clear difference in ReWI was calculated as rate of weight increase of the relative organ weight at the administered dose in comparison with the control, based on the corresponding data presented in Table 2 . Vol. 38 No. 2 TLR ratio between the thioamides and non-thioamides analyzed in this study. Because of this clear distinction, we believe this parameter to be of potential use for speculating on the possible mechanism of thyroid hyperplasia/hypertrophy found in repeated-dose toxicity studies of chemical substances. The relative weights of the liver and thyroid gland at 60 days were determined based on Figs. 1 and 4 in Hood et al. (1999) .
